fidgeting with Dexchlorpheniramine Generic Name: Dexchlorpheniramine maleate Dosage Form: oral solution Overview Side Effects Professional Interactions Pregnancy More Breastfeeding Warnings User Reviews Drug Images Support Group Q & A Dexchlorpheniramine MALEATE ORAL SOLUTION, USP 2 mg/5 mL Rx only Dexchlorpheniramine Description Each 5 mL (teaspoonful) contains: Dexchlorpheniramine Maleate, USP 2 mg Alcohol not more than 7.0% Dexchlorpheniramine Maleate, USP, an antihistamine agent, is a white, odorless crystalline powder that is freely soluble in water. The molecular formula is C 16 H 19 CIN 2 C 4 H 4 O 4 , designated chemically as (+)-2-[ p -Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine maleate (1:1). Inactive Ingredients Citric Acid; Dehydrated Alcohol; FD&C Red No. 40; Glycerin; Liquid Sugar; Menthol; Methylparaben; Natural and Artificial Orange Juice Flavor; Propylene Glycol; Propylparaben and Purified Water. May also contain Sodium Citrate for pH adjustment. The pH range is between 5.0 and 6.5. Slideshow 7 First Aid Kit Must Haves For Your Medicine Cabinet Dexchlorpheniramine - Clinical Pharmacology Dexchlorpheniramine maleate is an antihistamine with anticholinergic (drying) and sedative side effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells. Indications and Usage for Dexchlorpheniramine Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Amelioration of allergic reactions to blood or plasma Dermographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. Contraindications Use in Newborn or Premature Infants: This drug should not be used in newborn or premature infants. Use in Nursing Mothers: Because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. Use in Lower Respiratory Disease: Antihistamines should NOT be used to treat lower respiratory tract symptoms including asthma. Antihistamines are also contraindicated in the following conditions: Hypersensitivity to Dexchlorpheniramine maleate or other antihistamines of similar chemical structure Monoamine oxidase inhibitor therapy (See Drug Interaction section) Warnings Antihistamines should be used with considerable caution in patients with: Narrow angle glaucoma Stenosing peptic ulcer Pyloroduodenal obstruction Symptomatic prostatic hypertrophy Bladder neck obstruction Use in Children In infants and children, especially, antihistamines in overdosage may cause hallucinations, convulsions, or death. As in adults, antihistamines may diminish mental alertness in children. In the young child, particularly, they may produce excitation. Use in Pregnancy: Experience with this drug in pregnant women is inadequate to determine whether there exists a potential for harm to the developing fetus. Use with CNS Depressants: Dexchlorpheniramine Maleate, USP has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.). Use in Activities Requiring Mental Alertness: Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc. Use in the Elderly (approximately 60 years or older): Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients. Precautions Dexchlorpheniramine Maleate, USP has an atropine-like action and, therefore, should be used with caution in patients with: History of bronchial asthma Increased intraocular pressure Hyperthyroidism Cardiovascular disease Hypertension Drug Interaction: MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines. Adverse Reactions General: Urticaria, drug rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness of mouth, nose and the throat. Cardiovascular System: Hemolytic anemia, thrombocytopenia, agranulocytosis. Hematologic System: Hemolytic anemia, thrombocytopenia, agranulocytosis. Nervous System: Sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesias, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, hysteria, neuritis, convulsions. G.I. System: Epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation. G.U. System: Urinary frequency, difficult urination, urinary retention, early menses. Respiratory System: Thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness. Overdosage Antihistamine overdosage reactions may vary from central nervous system depression to stimulation. Stimulation is particularly likely in children. Atropine-like signs and symptoms dry mouth, fixed, dilated pupils, flushing, and gastrointestinal symptoms may also occur. If vomiting has not occurred spontaneously the patient should be induced to vomit. This is best done by having the patient drink a glass of water or milk after which the patient should be made to gag. Precautions against aspiration must be taken, especially in infants and children. Saline cathartics, such as milk of magnesia, draw water into the bowel by osmosis and therefore, are valuable for their action in rapid dilution of bowel content. Stimulants should not be used. Vasopressors may be used to treat hypotension. Dexchlorpheniramine Dosage and Administration DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT. Recommended Dosage Adults and Children 12 years of age and older: 2 mg (1 teaspoonful) Children 6 to 11 years: 1 mg (1/2 teaspoonful) Children 2 to 5 years: 0.5 mg (1/4 teaspoonful) Doses are generally given every 4 to 6 hours. How is Dexchlorpheniramine Supplied Dexchlorpheniramine Maleate Oral Solution, USP 2 mg/5 mL is supplied as a red-orange colored, orange flavored liquid in the following sizes: 16 fl oz (473 mL) RECOMMENDED STORAGE Store at (20 25 ) C ((68 77) F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with child-resistant closure. Rx Only Product No.: 8539 Manufactured By: Morton Grove Pharmaceuticals, Inc. Morton Grove, IL 60053 A50-8539-16 REV. 07-05 PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label MGP NDC 60432-539-16 Dexchlorpheniramine MALEATE ORAL SOLUTION, USP 2 mg/5 mL (Contains alcohol not more than 7.0%) DO NOT USE IF INNER FOIL SEAL PRINTED "SEALED FOR YOUR PROTECTION" IS BROKEN OR MISSING. BULK CONTAINER NOT FOR HOUSEHOLD USE Rx Only NET: 1 Pint (473 mL) Dexchlorpheniramine MALEATE Dexchlorpheniramine maleate solution Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:60432-539 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Dexchlorpheniramine Maleate (Dexchlorpheniramine) Dexchlorpheniramine Maleate 2 mg in 5 mL Inactive Ingredients Ingredient Name Strength SUCROSE GLYCERIN Water ALCOHOL METHYLPARABEN PROPYLPARABEN METHYL ALCOHOL PROPYLENE GLYCOL FD&C RED NO. 40 CAPTAN ANHYDROUS CITRIC ACID TRISODIUM CITRATE DIHYDRATE Product Characteristics Color RED, ORANGE Score Shape Size Flavor ORANGE Imprint Code Contains Packaging # Item Code Package Description 1 NDC:60432-539-16 473 mL in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA088251 03/23/1984 Labeler - Morton Grove Pharmaceuticals, Inc. (801897505) Revised: 08/2012 Morton Grove Pharmaceuticals, Inc. Next Interactions Print this page Add to My Med List More about dexchlorpheniramine Side Effects During Pregnancy or Breastfeeding Drug Images Drug Interactions Support Group 4 Reviews Add your own review/rating Drug class: antihistamines Consumer resources Dexchlorpheniramine Professional resources Dexchlorpheniramine (Wolters Kluwer) Related treatment guides Allergic Reactions Allergic Rhinitis} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Antihistamines Related Drugs antihistamines loratadine , cetirizine , Zyrtec , hydroxyzine , Claritin , promethazine Allergic Reactions prednisone , promethazine , loratadine , triamcinolone , diphenhydramine , Benadryl , EpiPen , Phenergan , epinephrine , cyproheptadine , Deltasone , chlorpheniramine , More... Allergic Rhinitis prednisone , Zyrtec , promethazine , fluticasone nasal , loratadine , cetirizine , Flonase , triamcinolone , montelukast , Claritin , Singulair , More... Dexchlorpheniramine Rating 4 User Reviews 7.8 /10 4 User Reviews 7.8 Rate it! Dexchlorpheniramine Images Dexchlorpheniramine systemic 4 mg (Amide 014 ) View larger images} } and have become
obligations Dexchlorpheniramine all of a sudden
EmoticonEmoticon